BioGaia signs new exclusive distribution agreement with Victus

BioGaia signs new exclusive distribution agreement with Victus
 
The agreement refers to sales of BioGaia's Probiotic drops and tablets in
Venezuela and Puerto Rico under the BioGaia brand. Launches are estimated to
take place during 2012.
 
BioGaia and Victus have had cooperation since 2001, when Victus started to buy
BioGaia's probiotic culture with Lactobacillus reuteri Protectis, for use in
Victus' product Glutapak-R. Since then Glutapak-R has been successfully marketed
by Victus in most countries in Latin America.
 
- Starting to sell BioGaia ProTectis Drops and Tablets strategically complements
more than ten years of successful experience with Glutapak-R. It is a natural
fit for both companies, say the owners of Victus, Enrique J. Lopez and Mariano
Macias.
 
- Considering Victus experience in promoting benefits of Lactobacillus reuteri
via their Glutapak Reuteri product, we are now looking forward to expanding our
cooperation, says Peter Rothschild, President of BioGaia.
 
Victus is specialised in nutrition and medical products and has subsidiaries and
distribution partners in the Latin American region since 1992.
 
For additional information please contact
Peter Rothschild, President, telephone: +46 8 555 293 00
 
BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 17 October 2011, 2:00
pm CET.
 
Latest press releases from BioGaia
2011-09-21              BioGaia signs agreement with the largest pharmaceutical
company in the Philippines for its probiotic chewable tablets
2011-08-18              BioGaia signs exclusive agreement with Fleet
Laboratories in U.S.
2011-08-17              BioGaia AB interim report 1 January - 30 June 2011
 
BioGaia is a biotechnology company that develops, markets and sells probiotic
                                    products
with documented health benefits. The products are primarily based on the lactic
                                      acid
bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing
                                    effects.
 The class B share of the Parent Company BioGaia AB is quoted on the Small Cap
                                      list
                  of the NASDAQ OMX Nordic Exchange Stockholm.
                                www.biogaia.com
 
Press release October 17, 2011: 
http://hugin.info/86913/R/1555335/479713.pdf
 
This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
 
Source: BioGaia AB via Thomson Reuters ONE
 
[HUG#1555335]